Expression of the p65 gene in patients with colorectal cancer: Comparison with some histological typing, grading and clinical staging

European Journal of Surgical Oncology

Volumn 30, Issue 3, 2004, Pages 266-270

  Balcerczak, M ^a   Balcerczak, E ^a   Pasz Walczak, G ^a   Kordek, R ^a   Mirowski, M ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Colorectal cancer; p65 gene; Reverse transcriptase polymerase chain reaction

Indexed keywords

SYNAPTOTAGMIN; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CANCER TISSUE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FREEZING; GENDER; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECTUM MUCOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLING; STATISTICAL ANALYSIS; TUMOR LOCALIZATION;

EID: 1842487569     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2003.11.006     Document Type: Article

References (17)

1. Mirowski M, Walaszek Z, Sherman U, Hanausek M. Comparative structural analysis of human and rat 65 kDa tumor-associated phosphoproteins. Int J Biochem 1993;25: 1865-1871.
2. Wang S, Mirowski M, Sherman U, Walaszek Z, Hanausek M. Monoclonal antibodies against a 65 kDa tumor-associated phosphoprotein: development and use in cancer detection. Hybridoma 1993;12:167-176.
3. Mirowski M, Klijanienko J, Wang S, Vielh P, Walaszek Z, Hanausek M. Serological and immunohistochemical detection of a 65 kDa oncofetal protein in breast cancer. Eur J Cancer 1994;30A:1108-1113.
4. Mirowski M, Walaszek Z, Hanausek M. Presence in bovine fetal serum of the protein antigenically related to p65-tumor associated antigen: Its isolation and polyclonal antibody production. Neoplasma 1997;43:83-88.
5. Niewiadomska H, Mirowski M, Stempien M, Blonski JZ, Hanausek M. Clinical evaluation of the usefulness of polyclonal and monoclonal antibodies raised against p65 protein in immunohistochemical diagnosis of breast cancer: A comparative study. Biomed Lett 1996;54:223-231.
6. Mirowski M, Błoński JZ, Niewiadomska H, Olborski B, Walaszek Z, Hanausek M, Woźniak L. Immunohistochemical study of 65-kDa oncofetal protein expression in breast cancer. Breast 1997;6:284-290.
7. Hanausek M, Wang S, Błoński JZ, Polkowska-Kulesza E, Walaszek Z, Mirowski M. Expression of an oncofetal 65-kDa phosphoprotein in lymphocytic and granulocytic leukemias. Int J Hematol 1996;63:193-203.
8. Wang S, Hanausek M, Walaszek Z, Mirowski M, Krokos C, Soriano TF. A new tumor marker (p65) facilitates the accurate detection of colorectal cancer. AACR 1994;35:231.
9. Balcerczak E, Bartkowiak J, Błoński JZ, Robak T, Mirowski M. Expression of gene encoding P65 oncofetal protein in acute and chronic leukemias. Neoplasma 2002;49:295-299.
10. Balcerczak E, Mirowski M, Jesionek-Kupnicka D, Bartkowiak J, Kubiak R, Wierzbicki R. p65 and c-erb B-2 genes expression in breast tumors: Comparison with some histological typing, grading and clinical staging. J Exp Clin Cancer Res 2003;22: 421-427.
11. Balcerczak E, Mirowski M, Sasor A, Wierzbicki R. p65, DD3 and c-erbB2 genes expression in prostate cancers. Neoplasma 2003;2:13-17.
12. Chomczyński P, Sacchi N. Single-step method of RNA isolation by guanidinum thiocyanate phenol chloroform extraction. Anal Biochem 1987;162:156-159.
13. Tokunaga K, Taniguchi H, Yoda K, Shimizu M, Sakiyama S. Nucleotide sequence of a full-length cDNA for mouse cytoskeletal β-actin mRNA. Nucleic Acid Res 1986;14: 2829-2836.
14. Hanausek M, Szemraj J, Adams AK, Walaszek Z. The oncofetal protein p65: A new member of the steroid/thyroid receptor superfamily. Cancer Detect Prev 1996;20:1-8.
15. Carson-Jurica MA, Schrader WT, O'Malley BW. Steroid receptor family: Structure and function. Endocr Rev 1990; 11:201-219.
16. Beato M. Gene regulation by steroid hormones. Cell 1989;6: 335-344.
17. Mirowski M, Hanausek M, Sherman U, Adams AK, Walaszek Z, Slaga TJ. An enzyme-linked immunosorbent assay for p65 oncofetal protein its potential as a new marker for cancer risk assessment in rodents and humans. In: D'Amato R, Slaga TJ, Farland WH, Henry C (eds) Relevance of animal studies to the evaluation of human cancer risk. 1992:281-294.